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ABSTRACT
Objective: to estimate the prevalence of disability 
serological of blood donors at the Regional Blood Center of 
Montes Claros, in the period 2009 to 2013. Methods: this is 
a transversal study, exploratory, through retrospective data 
collection, involving 2.101 donors unfit serologically. The 
study was approved by the CEP of Hemominas Foundation 
381/2014. Results: of the 82.743 candidates suitable for 
blood collection, 2.101 (2.5%) had reactive serologic tests, 
but only 1.434 (1.9%) confirmed the result through the 2nd 
sample collection. Among the diseases investigated, there 
was the following distribution prevalence of hepatitis B 
(anti-HBc) donors with 0.77% about the total of suitable, 
syphilis (0.41%), Chagas (0.40%), and others showed values 
below 0.08%. Conclusion: we concluded that in comparison 
with other studies, it was found that the prevalence of 
disability in our blood bank serological is similar, showing 
that the measures taken are safe. 
Descriptors: serology; blood donors; transmissible 
diseases.
RESUMO
Objetivo: estimar a prevalência da inaptidão sorológica dos doadores de 
sangue no Hemocentro Regional de Montes Claros, no período de 2009 a 
2013. Métodos: trata-se de um estudo transversal, de caráter exploratório, 
através da coleta de dados retrospectivos, que envolveu 2.101 doadores 
inaptos sorologicamente. O estudo foi aprovado pelo CEP da Fundação 
Hemominas nº381/2014. Resultados: do total de 82.743 candidatos aptos 
para a coleta de sangue, 2.101(2,5%) apresentaram testes sorológicos 
reativos, porém apenas 1.434 (1,9%) confirmaram o resultado através da 
coleta de 2ª amostra. Dentre as doenças pesquisadas, houve a seguinte 
distribuição de prevalência: hepatite B (anti-HBc) com 0,77% doadores 
em relação ao total dos aptos; sífilis (0,41%); Chagas (0,40%); e demais 
apresentaram valores abaixo de 0,08%. Conclusão: concluímos que 
em comparação com outros estudos, verificou-se que a prevalência de 
inaptidão sorológica em nosso hemocentro é semelhante, mostrando que 
as medidas adotadas são seguras.
Descritores: sorologia; doadores de sangue; doenças transmissíveis.
RESUMEN
Objetivo: estimar la prevalencia de la discapacidad serológica de donantes 
de sangre en el Centro Regional de Sangre de Montes Claros, en el período 
de 2009 a 2013. Métodos: estudio transversal, exploratorio, retrospectivo, 
involucrando 2.101 donantes no aptos serológicamente. El estudio fue 
aprobado por el CEP de Fundación Hemominas 381/2014. Resultados: de 
los 82.743 candidatos adecuados para la recogida de sangre, 2.101 (2,5%) 
tenían pruebas serológicas reactivas, pero sólo 1.434 (1,9%) confirmaron el 
resultado a través de la segunda toma de muestras. Entre las enfermedades 
investigadas, hubo la siguiente prevalencia de distribución: hepatitis 
B (anti-HBc) con 0,77% de donantes en relación al total de adecuados, 
sífilis (0,41%), Chagas (0,40%) y otros mostraron valores por debajo de 
0,08%. Conclusión: en comparación con otros estudios, se encontró que la 
prevalencia de la discapacidad serológica en banco de sangre es similar, lo 
que demuestra que las medidas adoptadas son seguras. 
Descriptores: serología; donantes de sangre; enfermedades transmisibles.
INTRODUCTION
Blood transfusion is important for meeting the needs 
of patients in cases of emergency (severe accidents) and 
treating patients with chronic, serious illnesses that require 
transfusions regularly as in the case of sickle cell anemia, 
thalassemia, clotting factor deficiencies (hemophilia and 
Von Willebrand disease, for example), myelodysplastic 
syndrome, bone marrow aplasia, among others.1 Then, it 
has shown to be an effective therapy and widely used in the 
treatment of various diseases.2
The transmission of infectious diseases by blood is known 
from the beginning of the twentieth century, even before 
there are the first blood banks. However, the onset of AIDS 
in 1981, and the evidence that the disease was transmitted by 
blood caused a revolution in world Blood Therapy services.3
The Ministry of Health states that for every donation, 
serological tests must be carried out for the following 
pathogens: HIV1 and HIV2, HTLV I and HTLV II, HCV, 
HBV, T. cruzi, Treponema pallidum, Plasmodium in endemic 
areas of malaria and CMV for immunosuppressed  patients.4 
These tests are laboratory screening procedures that define if 
a unit can be approved for transfusion, being released only 
those whose tests were negative for all markers required.5 
According to the legislation, ordinance 1353 of June 13th 2011, 
redefined the by ordinance 2,712, of November 12th 2013, it 
is mandatory to carry out highly sensitive laboratory tests 
in every donation.6-7 Thus, candidates for blood donation 
undergo clinical and serological screening to minimize the 
risk of disease transmission via transfusion.8
The country´s blood banks adopt measures as 
questionnaires about the general medical condition and 
exposure to sources of infection (hemodialysis, intravenous 
drug use, promiscuity); performing rigorous tests in all 
donated blood for tracing transmissible diseases. The 
presence of risk factors and seropositivity for blood 
transmissible diseases involve the immediate disposal 
of blood bags.9-10 In this context, it is estimated that the 
serological discard rate in the national blood banks ranges 
from 10% to 20%, being higher than in developed countries, 
mainly due to the high percentage of people who donate for 
the first time and which have a prevalence of infection close 
to the general population.11
The transmission of pathogens through transfusion 
needs basically that the donor has the circulating agent in 
his blood, the serological screening tests are unable to detect 
it and the host being susceptible. Furthermore, the tropism 
of certain infectious agents from the blood component 
determines the contamination of various blood components 
(red blood cells, platelet concentrates, leukocyte concentrates 
and plasma). In the transfusion, one of the limitations is the 
immunological window, which allows contaminated blood 
transfusion.8
In Brazil, until June 2014, it was reported in the System 
Born informatio– - SINAN NET, 70,677 cases of infection 
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by the human immunodeficiency virus (HIV) among adults 
and 773 in children.12 As to transmission among the older 
than 13 years old, sexually prevails. In women, 86.8% of the 
cases recorded in 2012 resulted from heterosexual sexual 
contact with HIV-infected people. Among men, 43.5% of the 
cases given by heterosexual contact, 24.5% by homosexual 
and 7.7% by bisexual. The rest occurred through blood 
and vertical transmission. Although the number of cases 
in males still is higher among heterosexuals, the epidemic 
in the country is concentrated (in population groups 
with behaviors that expose them to a greater risk of HIV 
infection, such as men who have sex with men, sex workers 
and drug users).13
The hepatitis B virus (HBV) is the only DNA virus that 
causes hepatitis in humans, belonging to the hepadnaviral 
family. Its main forms of transmission are a transfusion 
of blood or blood products, sex, perinatal transmission, 
intravenous drug use, organ and tissue transplantation, skin 
lesions or needle stick injuries. Therefore, infection with 
hepatitis B is a major public health problem.9,14
From data of blood banks, it is estimated six million 
people worldwide living with HBV.10 The tests required for 
the detection of hepatitis B are: - detection surface antigen of 
hepatitis B virus (HBV) - HBsAg; and antibodies detecting 
against HBV capsid anti-HBc (IgG or IgM + IgG).9
With the identification of hepatitis C virus (HCV), 
studies have shown that this agent was also responsible for 
90% of parenterally acquired hepatitis and at least 50% of 
the sporadic hepatitis non-A, non-B. For hepatitis C, the law 
measures the detection of antibody to HCV or combined 
detection of HCV antibody + antigen and detection of 
nucleic acid (NTA) of HCV.9
The human T-lymphotropic virus (HTLV) was the first 
isolated human retrovirus in 1980. In 1982, the second 
retrovirus with 60% homology with HTLV-I was isolated 
and named HTLV-II. Both the HTLV-I and II determine 
chronic infections with low viral replication rates, Adult 
T-cell leukemia/lymphoma (ATL) and remains most of the 
time in the incorporated provirus form the genomic DNA 
of the host lymphocytes.15-16 In Brazil, most of the data 
to investigate the prevalence of HTLV has been obtained 
from research conducted with donors of blood through 
transfusion services.16
Studies with blood donors in several Brazilian capitals 
showed that Salvador is characterized as the most endemic 
region for HTLV-I, with a registered seroprevalence around 
1.35%, followed by Recife and Rio de Janeiro with 0.33%, 
Belo Horizonte with 0.32% and this value was much higher 
than the 0.025% observed in the United States.16
Chagas disease is a tissue and hematologic infection 
caused by the flagellate protozoan Trypanosoma cruzi, 
whose natural vectors are insects of the order Hemiptera, 
and Triatoma infestations most important vector of the 
disease, described in 1909 by Carlos Chagas. Chagas disease 
is endemic only on the American continent and has 16 
million to 18 million people infected with approximately 
300,000 new cases per year, a significant cause of mortality 
of young adults, reducing in 13 years the expectation of life.17 
Today, legislation stipulates that the detection is through 
anti-T cruzi enzyme immunoassay antibody (IEE) or 
chemiluminescence (QLM).18-19
Syphilis is a chronic infectious disease caused by 
Treponema pallidum. In some countries, like Brazil, it is 
considered one of the major public health problems, similar 
to other emerging infectious diseases in the country.20
According to the World Health Organization, it is 
estimated about 12 million new cases of people infected 
each year with some disease related to sex, among which 
syphilis has great representation.21 Currently, the search 
for syphilis is done with specific and non-specific tests, and 
most laboratories have opted for Venereal Disease Research 
Laboratory (VDRL) and enzyme-linked immunosorbent 
assay (ELISA) for being easy to perform. According to the 
law, the test should be by detecting the anti-teponemal or 
non-treponemal antibody.6
In the last two decades, there has been more concern 
with ensuring transfusion safety. In parallel, an aging 
population, violence and accidents, associated with technical 
and scientific advances in the medical field have brought an 
increase in demand for transfusions, not always accompanied 
by an increase in the number of blood donors. For the safety 
of blood products to be used in transfusions, strict quality 
parameters should be followed.1 There must be functional 
systems that minimize the likelihood that one infected unit 
of the stock components available for transfusion to ensure 
that the blood and its components are as safe as possible.22
Laboratory screening for blood transmissible diseases 
is one of the most powerful tools in ensuring safety blood 
transfusion. However, alone, it is no guarantee of safe blood 
components. All procedures involving blood donation 
should be carried out in a structured and standardized 
form to minimize transfusion risks.23 Hence the importance 
of fulfilling efficiently the chemotherapeutic cycle, which 
begins with the collection and selection of donors, followed 
by serological and immuno-hematological screening, 
processing and fractionation of collected units, dispensation, 
transfusion, and post-transfusion evaluation.11
The lack of epidemiological data in Brazil, and more 
specifically in the North of Minas Gerais Region is a 
stimulus for this study, seeking greater knowledge about 
characteristics of this population, through data collection 
on infectious diseases of the donors of the Regional Blood 
Center Montes Claros-MG hills that is a reference to the 
North of Minas Gerais.
This study aimed to determine the frequency of the 
prevalence of serological markers of hepatitis B and C, HIV, 
HTLV I / II, syphilis and Chagas disease among blood donors 
attending the Montes Claros Regional Blood Center from 
2003 to 2013 and associate seroprevalence sociodemographic 
characteristics of these donors.
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METHODS
This is a cross-sectional, descriptive and quantitative 
study. The study population was candidates for blood 
donation at the Blood Center Regional Montes Claros-MG, 
in the period 2009-2013, which showed reactive serologic 
tests and confirmed the inability serologic by collecting the 
second sample n=1,434.
Secondary data from the Blood Center Blood Bank 
System were collected, coming from the standard procedure 
of screening and questionnaire completion prior to blood 
collection and also the results of serological tests for Chagas 
disease, HTLV I and HTLV II, AIDS, syphilis, Hepatitis B 
and C and adult T-cell leukemia/lymphoma recommended 
by the Ministry of Health. Thus, the variables in this study 
are part of a computerized database donors control (FDOA). 
This study also has the variables of gender (male and female), 
age group (18-29 years old and ≥30 years old), marital status 
(married, single or other) and type of donation (first time 
and repeat).
Statistical analysis were performed using the Statistical 
Package for Social Sciences - SPSS version 11.0 for Windows. 
Descriptive analyzes were performed with the presentation 
of absolute and relative frequencies and measures of central 
tendency and association analyzed with Chi-square and 
Fisher exact.
The study was approved by CEP Hemominas Foundation 
# 381/2014.
RESULTS 
The Montes Claros Regional Blood Center is the main 
blood donation center of Northern Minas Gerais assisting 
29 transfusion agencies, was one of the first cities in the state 
of Minas Gerais to house a Hematology core of Hemominas 
Foundation. It is a regional reference in the care of patients 
with hemoglobinopathies, coagulopathy and transfusion 
procedures for patients in outpatient conditions. It has about 
2,500 registered patients, 77% of patients with sickle cell 
anemia.
In 2012, the blood center received around 22,173 
candidates for blood donation, from the area and underlying 
regions of Montes Claros. Due to the loyalty of work carried 
out, 16,746 were eligible for donation, with a percentage 
of 29.6% new and 70.4% loyal donors, that is, repetition. 
This information and the approach found in a study in the 
hospital Santo Ãngelo - RS, between 2005 and 2010, where 
the total of candidates for donation was 24,862, and of these 
18,295 (73.6%) were eligible and 6,567 unsuitable (625 by 
serologic screening and 5,942 by hematological screening).24
In this study conducted from 2009 to 2013, a total of 
1,434 (1.9%) donors confirmed the result by the second 
sample and obtained reactive results, that is they were 
unfit for positive serology, being included and distributed 
according to gender, age, marital status, and type of donation 
as shown in Table 1.
Table 1: frequency distribution donor unsuitable for 
seropositivity in the 2009-2013 period.
Category Unfit
Gender
Male 789 (55.0%)
Female 645 (45.0%)
Age group
18-29 281 (19.6%)
≥30 1153 (80.4%)
Marital Status
Married 724 (50.5%)
Single 508 (35.4%)
Other 202 (14.1%)
Type of Donation
First time 1069 (74.5%)
Repetition 365 (25.5%)
The male was the one with the highest prevalence of 
gender. It is observed that the most affected age group 
corresponded to those who were 30 years old. Regarding 
marital status, there was a prevalence among married. It also 
became evident an increase among first-time donors.
A study in the Blood Bank of Uberaba-MG found the 
prevalence of male donors (73%) and in age, there was slightly 
higher than for people over 30 years old25, corroborating the 
findings of this work. In research on first-time blood donors 
in Recife, there was also a prevalence of males (73%) and 
about 48% were married or had a stable relationship.26 In 
another study, the public blood bank of Natal-RN again was 
detected the predominance of the male gender, age over 29 
years old and regarding marital status, indices were similar 
between married (48.1%) and single (47.9%).27  A similar 
situation to that found in Santa Cruz do Sul-RS, in which 
the total number of surveyed individuals, both married as 
singles accounted for 46.4%.28 A research of Rohr et al.24 
although performed with unsuitable in clinical screening, 
profiling the candidates matches this work as the gender 
(most male) and the fact of being a spontaneous donor. 
However, it differed with the age, since most were between 
18 and 23 years old. Different from these research, Belato et 
al..29 research revealed that 50% of donors were women, and 
50% were men.
Regarding the prevalence of male gender, a study of 
Anvisa30 found that more men seek the blood donation 
service. Probably, this is the reason for the number of unfit 
men beeing higher than womens.24,31-32
Table 2 describes the prevalence of unsuitable donations 
by serology. From these data, it was found a significant 
increase in the percentage of the virus for hepatitis 
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B-anti-HBc marker (0.77%), followed by syphilis-related 
diseases (0.41%) and Chagas (0.40%).
Alves et al.9 study showed that 1.97% of unsuitable donors, 
from 1995 to 2009, had positive serology for HBV. Moraes-
Souza study25 showed non-negative serology for Chagas 
of 0.31% and study of Melo et al..33, made in Pernambuco 
reported that 39.70% of donors had reagent serology for 
Chagas, and of these, 60.30% were for inconclusive serology. 
In another study of 218,989 donors considered suitable 
by serology, 0.2% were ineligible because positive for 
Chagas disease.34
Table 2: prevalence of unsuitable donations by serology at 
the Regional Blood Center of Montes Claros, in 2009-2013.
Disease
Prevalence by 
the total of 
donors
Prevalence by the 
number of unsuitable 
donors
Syphilis 0,41% 343 (23.9%)
HbSAg 0,08% 65 (4.5%)
HBC 0,77% 637 (44.4%)
HCV 0,06% 52 (3.6%)
CHAGAS 0,40% 326 (22.7%)
HIV1 0,07% 64 (4.5%)
HIV2 0,05% 43 (3.0%)
HTLV 0,06% 49 (3.4%)
Total of 
donors 82743 1434
The association between gender, age, type of donation, marital status for the group of communicable diseases (syphilis, 
anti-HBc, HCV, HIV/I and HIV/II), is shown in Table 3.
Table 3: distribution of age, gender, type of donation and marital status about disability by diseases transmitted by transfusion.
Group
Gender
M                      
F
P*
Age
18-29           
>30
P*
Type of 
Donation
First time              
R
P*
Marital status
Married      
Single      Other
P
Syphilis
Pos
203                   
140
0.082
60                  
283
0.276
216                
127
0.000
167              113              
63
0.031
Neg
586                   
505
221                 
870
853                
238
557              395      
139
HBC
Pos
368                    
269
0.062
141                 
496
0.032
533                
104
0.000
326              239       
72
0,020
Neg
421                    
376
140                 
657
536                
261
398              269      
130
HCV
Pos
25                      
27
0.323
14                   
38
0211
28                   
24
0.001
18                25               
9
0.063
Neg
764                    
618
267                
1115
1041                 
341
706              483      
193
HIV1
Pos
34                      
30
0.798
28                    
36
0000
38                   
26
0.004
23                34        
7
0.010
Neg
755                    
615
253                
1117
1031                 
339
701              474       
192
HIV2
Pos
22                      
21
0.642
10                    
33
0558
19                    
24
0.000
21                15                
7
0.914
703               493    
195
Neg
767                    
624
271                
1120
1050                 
341
*  Chi-square test 
**  Fisher’s exact test
It was found that with regard to age, there was no statistically significant difference with the marker for HIV/I (p=0.000) 
and with the anti-HBc marker (p=0.032).
For the type of donation, there was no difference with syphilis (p=0.000), anti-HBc (p=0.000), HCV (p=0.001), HIV/I 
(p=0.004) and HIV/II (p=0.000). Marital status with syphilis (p=0.031), anti-HBc (p=0.020) and HIV/I (p=0.010). The other 
parameters were not statistically significant.
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The prevalence of disability serological hepatitis B 
virus (HBV) in this study was 0.77%, and the hepatitis C 
virus (HCV) was 0.06% about the total of suitable donors, 
demonstrating a greater prevalence of hepatitis B in the 
northern region of Minas Gerais. On average, in Brazil, this 
prevalence is around 8%. In the southern states is about 
of 0.3% to 1.7% in São Paulo and Rio de Janeiro from 1.0 
to 2.1%, which shows the similarity of this study to other 
described before.13 In a study performed in the Blood Bank 
of Uberaba - MG, the prevalence was 5.6% compared to 
HBV, and males predominated, age older or equal to 30 years 
old, marital status as married.9 In another study, it was found 
that 0.37% of donors are unsuitable by HCV.35
However, in the Northeast and the Amazon region, 
the prevalence is around 2.8% to 10.3%. In this sense, it 
confirms the heterogeneity of our country.13 In England, 
the prevalence of viral hepatitis in blood donors is low and 
decreasing: 0:39:100,000 donations for the hepatitis B virus 
(HBV) and 0:17:100,000 donations for hepatitis C ( HCV). 
These rates are much lower than the rates reported in the 
United States (1:63.000 HBV; 1:103,000 HCV) and France 
(1:112,000 HBV; 1: 217,000 HCV). In Brazil, the prevalence 
of viral hepatitis rates in blood banks are not negligible for 
markers of hepatitis B and C: 0.3% - 1.5% for HBsAg; 3.7% - 
11.1% for anti-HBc and 0.9% - 2.6% anti-HCV.36
For this study, the prevalence of syphilis was 0.41% which 
reinforces similar findings in the study of Borelli et al..37 at 
the Blood Center of Maringá, Paraná. On the other hand, 
the positivity rate for the pathology in Guarapuava (PR) was 
2.1%, so a higher rate than that reported in the current study. 
Research in other states of blood centers also showed a high 
positivity rate for syphilis testing, as well as in the Brazilian 
states of Amazonas, São Paulo and Sergipe.37
Regarding the prevalence of syphilis, which in this 
study was 0.41% and hepatitis B (0.77%), together have 
demonstrated a high disability rate serologic, corroborating 
studies by Rodriguez et al.,38 Salles et al.,39 Carrazone 
et al.,22 and data obtained from the National Health 
Surveillance Agency.40
The prevalence of hepatitis B and syphilis as the main 
pathologies associated with serological screening may 
be linked to the fact that currently the population has a 
cumulative effect of behavioral risks. These mainly involve 
unprotected sex, since these diseases are mainly transmitted 
through sexual intercourse, the use of illicit injectable drugs 
and other exposures to blood and blood products.1
Analyzing the rate of Chagas disease in this study (0.40%), 
it was relatively low compared with rates of 1.1% and 1.9% in 
other studies.41-42 This analysis shows that currently there was 
a significant decrease in transmission of Chagas disease in 
Brazil, estimated at between three and twenty occurrences 
in the context of more than 4 million annual transfusions.43
This decrease may be explained by a different proportion 
of rural migrants in urban areas between the 70 and 80, 
or perhaps for the better management of the disease and 
reducing transmission.44
In tests of association between the diseases (syphilis, HIV, 
and HTLV) and marital status, in participants with negative 
serology, the proportion of married couples is higher than in 
those with positive serology.
CONCLUSION
The rate of unsuitable serological blood banks in Brazil 
ranges from 10 to 20%.39 Currently, ANVISA recommends 
that the suitable serological rate is less than 8.3%. The 
results of the serological prevalence of unsuitable from 
this study are with values below the national parameters. 
Thus, it is concluded that epidemiological surveillance is 
an essential tool for determining the risk of infection and 
profile of infected patients, enabling the implementation of 
prevention and maintenance measures of reduced serum 
values, requiring a collection of constant epidemiological 
information to improve the research and reporting process.
The acquisition of new customers has been one of the 
biggest challenges for the institution. It requires a constant 
educational program, to increase the number of spontaneous 
and regular donors, but if not careful; it can increase the 
incidence of seropositivity in a first blood donor.
One effective measure is to conduct educational 
campaigns and quality information to the public about blood 
donation. With this awareness, a voluntary and altruistic 
donation will increase, and consequently a better profile of 
donors, improving safety on donation.
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